💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Compugen Ltd. (CGEN)
« Back to company indexCGEN Chatter Timeline
Stock Ticker for CGEN
Most Active Tweeters for CGEN
| User | Tweets |
|---|---|
| @PennySearch | 4 |
| @HisaApp | 3 |
| @Jayriq | 3 |
| @Tickeron | 3 |
| @hesham_monica | 2 |
Recent Tweets for CGEN
 |
@Tickeron $CGEN enters a Downtrend as Momentum Indicator dropped below the 0 level on January 12, 2022. View odds for this an… https://t.co/k2Kr2YQvHm January 25th 2022, 3:01am |
 |
@ShortAlgoTrades $CGEN Waiting for Buy signal. Chart by https://t.co/jpmUt7BvVp https://t.co/HIQUenrc03 January 24th 2022, 5:01pm |
 |
@ShogunTrade $CGEN Awaiting Buy Signal. Chart by https://t.co/6vnULU2sSf https://t.co/RPTggtIsSt January 24th 2022, 11:01am |
|
@Tickeron A.I.dvisor made a bearish call on $CGEN, netting in a 11.38% gain over 2 weeks #Compugen #stockmarket #stock… https://t.co/dfk1pmIv0Z January 24th 2022, 3:01am |
 |
@hesham_monica $CGEN Awaiting Buy Signal. Free Trial https://t.co/wUyihfppva https://t.co/lTtToNDOrq January 21st 2022, 8:01pm |
 |
@PennySearch $CGEN SVB Leerink gave CGEN a Outperform stock rating on 2021-04-06. Find top penny stocks with PennySearch befo… https://t.co/C8bToOLVqN January 21st 2022, 11:01am |
|
@PennySearch $CGEN SVB Leerink gave CGEN a Outperform stock rating on 2021-04-06. Find top penny stocks with PennySearch befo… https://t.co/Yn4mwaJ2KS January 20th 2022, 9:01pm |
 |
@TradeWithAlerts Nice print for $CGEN Size: 113436 Price: 3.81 Amount: $432,191.16 Time: 1600 See more: https://t.co/0RRWcExgkP Join… https://t.co/bvmuFC56yq January 20th 2022, 9:01pm |
 |
@kasiva_mutisya RT @Jayriq: Car and General ( $CGEN) closes today at Kes 76. Crazy rally over the last 3 weeks from about Kes 31 at the start of the year!… January 19th 2022, 5:01pm |
 |
@_ademba_ Our broker doesn't have $CGEN kwa market watch na venye we wanted to sell. Just taking us thru the corners January 19th 2022, 3:01pm |
 |
@Jayriq Car and General ( $CGEN) closes today at Kes 76. Crazy rally over the last 3 weeks from about Kes 31 at the start o… https://t.co/tFzAQchGgJ January 19th 2022, 2:01pm |
 |
@A1Syad $CGEN Bullish pattern building. Chart by https://t.co/1MjnDHV7ua https://t.co/izCXcemPh9 January 18th 2022, 7:01pm |
|
@PennySearch $CGEN SVB Leerink gave CGEN a Outperform stock rating on 2021-04-06. Find top penny stocks with PennySearch befo… https://t.co/PX2AUUgwpO January 18th 2022, 5:01pm |
 |
@mehabecapital $CGEN @ 3.84 (-1.54%) : Compugen gets US patent for COM701 combo use in cancer https://t.co/NmkdRaHl5S January 18th 2022, 3:01pm |
 |
@Steven38199694 $CGEN Compugen announces issuance of new US patent covering triple combination of checkpoint inhibitors: 1. COM701… https://t.co/kC2lPqxGks January 18th 2022, 3:01pm |
 |
@brentkhack $CGEN added with U.S. patent for method of use of cancer drug candidate January 18th 2022, 2:01pm |
 |
@newsinthemarket Compugen granted U.S. patent for COM701 antibody $CGEN January 18th 2022, 12:01pm |
 |
@OryoJohn $CGEN: Compugen Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use… https://t.co/cYSJeBP86N January 18th 2022, 12:01pm |
 |
@FlashAlert_me $CGEN [15s. delayed]: Issued Press Release on January 18, 07:00:00: Compugen Expands COM701 Intellectual Property P… https://t.co/6x3QFV1huY January 18th 2022, 12:01pm |
 |
@Snatch_Trading $CGEN Compugen Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use… https://t.co/ib8C6kElNY January 18th 2022, 12:01pm |
 |
@mikalche $CGEN Compugen Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use… https://t.co/EVCCFA3xPZ January 18th 2022, 12:01pm |
 |
@StockNewsBot2 $CGEN Compugen Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use… https://t.co/vMihKzxDHJ January 18th 2022, 12:01pm |
 |
@stock_titan $CGEN Compugen Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use… https://t.co/4yms8B9g81 January 18th 2022, 12:01pm |
|
@Tickeron $CGEN enters a Downtrend as Momentum Indicator dropped below the 0 level on January 12, 2022. View odds for this an… https://t.co/vwISXaECLO January 18th 2022, 10:01am |
 |
@HisaApp #KenyaMarketUpdate Few hours into trading, $CGEN is leading the gainers with a 9.88% share price appreciation while… https://t.co/3gp2YT60zD January 18th 2022, 9:01am |
 |
@VatqLu $CGEN Waiting for Buy signal. https://t.co/J5JRPiuni4 January 17th 2022, 8:01pm |
 |
@LeeRosasi @cheruiyotkb My current situation with $CGEN. I waited for 23bob, I saw it today at a range around 63bob January 17th 2022, 2:01pm |
|
@hesham_monica $CGEN Awaiting Buy Signal. Free Trial https://t.co/wUyihfppva https://t.co/yVaB0aoLDc January 17th 2022, 1:01pm |
|
@Jayriq RT @HisaApp: #NSEMarketUpdate $CGEN is currently the top gainer ( +9.91%) while $SGL is the current top loser (-9.03%)... https://t.co/XFGn… January 17th 2022, 10:01am |
|
@HisaApp #NSEMarketUpdate $CGEN is currently the top gainer ( +9.91%) while $SGL is the current top loser (-9.03%)... https://t.co/XFGnGPFd1h January 17th 2022, 9:01am |
|
@PennySearch $CGEN SVB Leerink gave CGEN a Outperform stock rating on 2021-04-06. Find top penny stocks with PennySearch befo… https://t.co/ZBLPc5yJnY January 17th 2022, 8:01am |
 |
@wonenownlee @FinancialAdvBot I'm too far into $CGEN. $VXRT I've had January 16th 2022, 4:01am |
 |
@Ba4Saso $CGEN Awaiting Buy Signal. Free 7 Day Trial at https://t.co/z6vAd7dl0q https://t.co/krm9GfnaSW January 15th 2022, 8:01pm |
 |
@FinancialAdvBot Grab some $CGEN! https://t.co/30lfeBISxV January 15th 2022, 6:01am |
 |
@asayre07 @choffstein @ToddCFRA So for a company like $CGEN its going to be more influenced by ARK buys than anything else? January 15th 2022, 3:01am |
 |
@kennekai RT @my_tradesignals: $CGEN +93% this week. https://t.co/X9RAcqQLx3 January 14th 2022, 6:01pm |
 |
@Kevo_jr On 22/12/20221 $CGEN closed at Kes. 33.90 today it closed at Kes. 58 ????? Demand > Supply #NSE https://t.co/7HXOsmiMW2 January 14th 2022, 4:01pm |
|
@Jayriq RT @HisaApp: #NSEMarketUpdate $CGEN is the current top gainer (+9.72%) while $FAHR is the current top loser (-1.84%)... https://t.co/Jtu97J… January 14th 2022, 9:01am |
|
@HisaApp #NSEMarketUpdate $CGEN is the current top gainer (+9.72%) while $FAHR is the current top loser (-1.84%)... https://t.co/Jtu97JazUS January 14th 2022, 9:01am |
 |
@mytradesignals $CGEN +93% this week. https://t.co/BSFnrTheX5 https://t.co/X9RAcqQLx3 January 14th 2022, 8:01am |
 |
@traderMJT $CGEN Cathie Wood is buying this stock, still. Maybe just maybe she'll be right in the end, but it's as if she does… https://t.co/7vP0ZhY84I January 14th 2022, 1:01am |
|
@VatqLu $CGEN Waiting for Buy signal. https://t.co/RHWG4z1tMn January 13th 2022, 3:01pm |
 |
@MaiteMerenda $CGEN Almost ripe for a run Chart by https://t.co/t5kOjgsWN3 https://t.co/RsXUxuW2tB January 11th 2022, 4:01pm |
|
@A1Syad $CGEN Awaiting Buy Signal. Chart by https://t.co/1MjnDHV7ua https://t.co/5Qz5hNkijo January 11th 2022, 12:01pm |
|
@HisaApp #NSEMarketUpdate $CGEN currently leading the gainers with a 9.95% share appreciation price while $KUKZ is currently… https://t.co/1NS2vsSiGt January 11th 2022, 9:01am |
 |
@ValentinDobchev @SovereignTrades @Matthew01545150 https://t.co/Od7fCP1JzQ $CGEN from 11/11. Same exact chart. I usually have levels… https://t.co/y66dr6q54Y January 10th 2022, 6:01pm |
|
@hesham_monica $CGEN Awaiting Buy Signal. Free Trial https://t.co/wUyihfppva https://t.co/2XGEjLQQqj January 10th 2022, 1:01pm |
 |
@cheycheykule $CGEN up 9.85% today on this news https://t.co/srNFUstV9j via @BD_Africa January 10th 2022, 10:01am |
|
@PennySearch $CGEN SVB Leerink gave CGEN a Outperform stock rating on 2021-04-06. Find top penny stocks with PennySearch befo… https://t.co/hhChhKtqJB January 9th 2022, 4:01pm |
|
@PennySearch $CGEN SVB Leerink gave CGEN a Outperform stock rating on 2021-04-06. Find top penny stocks with PennySearch befo… https://t.co/saR1qc2Htn January 8th 2022, 11:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?